amobarbital has been researched along with Cardiac Diseases in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| TAMAGNA, IG | 1 |
| POINDEXTER, CA | 1 |
| Buchtal, A | 1 |
| Hanson, GC | 1 |
| Peisach, AR | 1 |
2 other studies available for amobarbital and Cardiac Diseases
| Article | Year |
|---|---|
A comparative evaluation of tetraethylammonium chloride and sodium amytal in patients with hypertensive cardiovascular disease.
Topics: Amobarbital; Cardiovascular Diseases; Cardiovascular System; Disease; Heart Diseases; Hypertension; | 1948 |
Transcutaneous aortovelography. Potentially useful technique in management of critically ill patients.
Topics: Adult; Aged; Amobarbital; Aorta, Thoracic; Blood Flow Velocity; Cardiac Output; Female; Heart; Heart | 1976 |